256 filings
Page 7 of 13
8-K
9my6 97xfd
21 Aug 19
Entry into a Material Definitive Agreement
8:02am
8-K
9f842u4m 7aw8
7 Aug 19
Cara Therapeutics Reports Second Quarter 2019 Financial Results
4:12pm
8-K
1ctuk9rwvzbba z9
29 Jul 19
Cara Therapeutics Announces Pricing of $126.5 Million Offering of Common Stock
4:11pm
424B5
25mc5bn
25 Jul 19
Prospectus supplement for primary offering
4:42pm
424B5
ev75g47tj92aq9pnbh
24 Jul 19
Prospectus supplement for primary offering
4:39pm
8-K
276gew3crmro acs
24 Jul 19
Cara Therapeutics Announces Proposed Offering of Common Stock
4:15pm
8-K
d70rws
12 Jul 19
Entry into a Material Definitive Agreement
4:10pm
8-K
g6ob4zys2s3nu y925
5 Jun 19
Submission of Matters to a Vote of Security Holders
5:19pm
8-K
t10cih2i4bch5l3dyqx
29 May 19
Cara Therapeutics Announces Positive Results From
7:17am
8-K
wtmcrv
7 May 19
Cara Therapeutics Reports First Quarter 2019 Financial Results
4:10pm
DEFA14A
lc3vdyjcvs
24 Apr 19
Additional proxy soliciting materials
4:18pm
EFFECT
48hs9e
5 Apr 19
Notice of effectiveness
12:15am
CORRESP
w5mrr8fks ly2n0a
2 Apr 19
Correspondence with SEC
12:00am
UPLOAD
hevnngov w5yghe
22 Mar 19
Letter from SEC
12:00am
CT ORDER
5fodmbi zjfm
21 Mar 19
Confidential treatment order
9:54am
S-8
w1lak0go
15 Mar 19
Registration of securities for employees
4:34pm